TherapeuticsMD
TXMD
82 hedge funds and large institutions have $442M invested in TherapeuticsMD in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 12 closing their positions.
981% more call options, than puts
Call options by funds: $1.58M | Put options by funds: $146K
133% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 18
15% more capital invested
Capital invested by funds: $383M → $442M (+$59M)
0.03% more ownership
Funds ownership: 1.19% → 1.22% (+0.03%)
6% less funds holding
Funds holding: 87 → 82 (-5)
42% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$15.2M |
| 2 |
Bank of New York Mellon
New York
|
+$12.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$12M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$7.31M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$2.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCM
Century Capital Management
Boston,
Massachusetts
|
-$8.43M |
| 2 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$4.28M |
| 3 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$2.27M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$661K |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
-$552K |
TXMD Hedge Fund Activity: Q3 2014 in Review
82 of the 3,455 institutional investors tracked by Wall St. Rank reported a position in TherapeuticsMD (TXMD) for Q3 2014, worth a combined $442M — up 15% from $383M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TXMD and 7 opened new positions — a net loss of 5 holders — while 18 trimmed existing stakes and 42 added.
The largest buyer was State Street, adding an estimated $15.2M. The largest seller was Century Capital Management, exiting entirely with an estimated $8.43M sold.
- 82 institutional investors held TherapeuticsMD (TXMD) as of Q3 2014, down from 87 in Q2 2014.
- Funds reported $442M of TherapeuticsMD stock for Q3 2014, up 15% quarter-over-quarter.
- 7 funds opened new TherapeuticsMD positions in Q3 2014 and 12 closed out, a net change of -5 holders.
- The largest TherapeuticsMD buyer in Q3 2014 was State Street, an estimated $15.2M added.
- The largest TherapeuticsMD seller in Q3 2014 was Century Capital Management, an estimated $8.43M sold.
Based on aggregated 13F filings for Q3 2014.